I read all their press releases as well as the sec filings, especially the ones where they are paying people to pump the stock when that money should be going to build the business. And for clarification, pumping the stock has NOTHING to do with building the business.
Wow, you are a ray of sunshine. Why are you still here? If you are not invested in IVOB, what is your intent with the ongoing juvenile name calling?
I would say that given the large global market for infertility treatment once IVOB can get past the funding hurdle for FDA approval, the sky is the limit for this stock. That is why a third party objective assessment of IVOB by Zachs Investment Research pegs the fair value of the stock at $0.25.